Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

GLP-1 drugs like Ozempic, Mounjaro, Wegovy, and Zepbound are powerful tools for treating diabetes and aiding with weight loss ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...

The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Becton, Dickinson and Company's prefilled syringes and self-administered injection systems could be used for GLP-1 market.